BlueCare Discovery is a young DeepTech startup specializing in marine biotechnology. The company is a pioneer in developing bioinspired pharmaceutical compounds derived from microalgae, designed for precision medicine.

By harnessing the exceptional diversity of these microorganisms, BlueCare Discovery identifies and develops molecules with unique therapeutic properties, addressing medical unmet needs, particularly in the prevention of certain neurodegenerative diseases.

These targeted biotherapies tackle major challenges in human health by offering more biocompatible treatments, aligned with sustainable development goals.